I may spend more time reading through some stuff, but I don't really know much more than anyone else. All this stuff is new to me. What I believe is most of us simply are seeking the truth. medchem is a truth seeker. The post by another poster was misleading the way it was posted here. It gave the impression Algernon was entering a Phase 3 trial. I though the exact same thing at first glance, Until I went to the actual link and read through the sourced information. From what I could tell the Phase 3 was for another company on the list. However, that does not mean Algernon will not enter into a Phase 3 trial. I simply don't know. What I do know is whether it's a Phase 2 or Phase 3 doesn't matter. The point is getting drugs into consenting patients and getting positive results. We must keep in mind Algernon has a global strategy. Algernon unleashed a blitz of news releases (March 16,2020) in 11 different languages across Asia. My take on that is Algernon has the drugs necessary to conduct trials throughout Asia and/or USA.
Dr. Mark Williams explains the clinical trial(s) pathway in the BioPub video.
See BioPub video at 12:50 to 18:30 min/sec mark:
The bottom line is we need to know if NP-120 (Ifenprodil) can help. Whether it's through US FDA or Asia, the goal is to get results now versus later. The FDA is not Algernon's target audience. Algernon's target audience is Big Pharma. But let us be clear, Algernon IS coming to the aid of All of Mankind.
News 
Market Data 
Discover 
